Inter Pharma PCL (BKK:IP)
Thailand flag Thailand · Delayed Price · Currency is THB
4.380
+0.060 (1.39%)
Feb 11, 2026, 11:48 AM ICT

Inter Pharma PCL Balance Sheet

Millions THB. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
302.44184.6412.39776.42173.87152.33
Short-Term Investments
10.930.860.830.80.77
Cash & Short-Term Investments
303.43185.53413.25777.25174.67153.09
Cash Growth
38.35%-55.10%-46.83%344.99%14.09%-55.34%
Accounts Receivable
359.03376.06337.32340.3258.11124.38
Other Receivables
83.2971.3787.7451.8934.0831.49
Receivables
442.32447.43425.06392.2292.25155.93
Inventory
356.78339.49351.82332.98192107.65
Other Current Assets
7.149.3512.7212.787.70.61
Total Current Assets
1,110981.81,2031,515666.61417.28
Property, Plant & Equipment
1,1871,150929.27880.77457.32255.39
Long-Term Investments
40.5541.7843.379.3510.12-
Goodwill
563.1477.85477.85477.8522.1622.16
Other Intangible Assets
215.81204.46197.36167.7955.148.58
Long-Term Deferred Tax Assets
20.1220.1715.919.818.983.38
Other Long-Term Assets
61.99144.4285.7529.52106.769.5
Total Assets
3,2013,0212,9523,0901,327756.33
Accounts Payable
208.88184.6200.52193.7969.6558.49
Accrued Expenses
49.8646.0347.0634.7415.9211.69
Short-Term Debt
119.3379.9146.3448.73131.0111.01
Current Portion of Long-Term Debt
6455.254.4372.5135.6215.53
Current Portion of Leases
31.6426.6438.8930.460.570.64
Current Income Taxes Payable
13.6511.844.1125.1814.88.4
Current Unearned Revenue
9.44.59----
Other Current Liabilities
124.6117.4787.3992.5568.0654.58
Total Current Liabilities
621.36526.29478.75497.95335.63160.35
Long-Term Debt
138.98167.19205.46319.61187.0690.91
Long-Term Leases
61.265.554.8367.691.92.47
Pension & Post-Retirement Benefits
47.2740.8832.7531.1415.418.54
Long-Term Deferred Tax Liabilities
56.2158.2259.2155.333.537.62
Other Long-Term Liabilities
11.178.323.662.14--
Total Liabilities
936.19866.4834.65973.86543.54269.89
Common Stock
302.67302.67186.26186.26149.01103
Additional Paid-In Capital
1,4981,4981,4981,498492.09304.98
Retained Earnings
228.73132.41225.25238.26116.8558.16
Comprehensive Income & Other
3.73.73.73.73.73.7
Total Common Equity
2,0331,9371,9131,926761.64469.85
Minority Interest
231.64217.4204.53190.2521.8616.59
Shareholders' Equity
2,2652,1542,1182,116783.5486.44
Total Liabilities & Equity
3,2013,0212,9523,0901,327756.33
Total Debt
415.14394.45399.95539356.17120.57
Net Cash (Debt)
-111.71-208.9213.3238.25-181.532.53
Net Cash Growth
---94.42%---90.25%
Net Cash Per Share
-0.18-0.350.020.45-0.380.07
Filing Date Shares Outstanding
605.34605.34605.35605.35484.27468.65
Total Common Shares Outstanding
605.34605.34605.35605.35484.27468.65
Working Capital
488.3455.51724.11,017330.98256.93
Book Value Per Share
3.363.203.163.181.571.00
Tangible Book Value
1,2541,2541,2381,281684.38399.11
Tangible Book Value Per Share
2.072.072.052.121.410.85
Land
-333.9327.63327.63183.25117.3
Buildings
-534.98430.08404.55177.1366.64
Machinery
-379.84346.66310.51148.3105.7
Construction In Progress
-174.8557.1715.970.331.1
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.